BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9763194)

  • 1. Detection of DNA amplification in human renal cell carcinoma cell lines using restriction landmark genomic scanning.
    Cho M; Konishi N; Kitahori Y; Hiasa Y; Nakagawa Y; Uemura H; Hirao Y; Oosterwijk E
    Cell Mol Biol (Noisy-le-grand); 1998 Sep; 44(6):913-8. PubMed ID: 9763194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic alterations in human prostate carcinoma cell lines by two-dimensional gel analysis.
    Konishi N; Tao M; Nakamura M; Kitahaori Y; Hiasa Y; Nagai H
    Cell Mol Biol (Noisy-le-grand); 1996 Dec; 42(8):1129-35. PubMed ID: 8997517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of genetic alterations in the human gastric cancer cell lines by two-dimensional analysis of genomic DNA.
    Kim YS; Yoo HS; Lee KT; Goh SH; Jung JS; Oh SW; Baba M; Yasuda T; Matsubara K; Nagai H
    Int J Oncol; 2000 Aug; 17(2):297-308. PubMed ID: 10891539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma.
    Kaku H; Ito S; Ebara S; Ouchida M; Nasu Y; Tsushima T; Kumon H; Shimizu K
    Urology; 2004 Jul; 64(1):176-81. PubMed ID: 15245966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma.
    Okuda H; Toyota M; Ishida W; Furihata M; Tsuchiya M; Kamada M; Tokino T; Shuin T
    Oncogene; 2006 Mar; 25(12):1733-42. PubMed ID: 16278676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning.
    Hirotsune S; Hatada I; Komatsubara H; Nagai H; Kuma K; Kobayakawa K; Kawara T; Nakagawara A; Fujii K; Mukai T
    Cancer Res; 1992 Jul; 52(13):3642-7. PubMed ID: 1617637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different patterns of DNA alterations detected by restriction landmark genomic scanning in heterogeneous prostate carcinomas.
    Konishi N; Hiasa Y; Nakamura M; Kitahori Y; Matsubara K; Nagai H
    Am J Pathol; 1997 Jan; 150(1):305-14. PubMed ID: 9006345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of DNA sequences from chromosome 19q13.1 in human pancreatic cell lines.
    Curtis LJ; Li Y; Gerbault-Seureau M; Kuick R; Dutrillaux AM; Goubin G; Fawcett J; Cram S; Dutrillaux B; Hanash S; Muleris M
    Genomics; 1998 Oct; 53(1):42-55. PubMed ID: 9787076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal cell carcinoma genetic analysis by comparative genomic hybridization and restriction fragment length polymorphism analysis.
    Presti JC; Moch H; Reuter VE; Cordon-Cardo C; Waldman FM
    J Urol; 1996 Jul; 156(1):281-5. PubMed ID: 8648824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma.
    Furge KA; Chen J; Koeman J; Swiatek P; Dykema K; Lucin K; Kahnoski R; Yang XJ; Teh BT
    Cancer Res; 2007 Apr; 67(7):3171-6. PubMed ID: 17409424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of multifocal renal cell carcinoma by comparative genomic hybridization.
    Junker K; Hindermann W; Schubert J; Schlichter A
    Anticancer Res; 1999; 19(2C):1487-92. PubMed ID: 10365129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
    Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM
    Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic characterization of lung metastases in renal cell carcinoma.
    Junker K; Sänger J; Schmidt A; Hindermann W; Presselt N; Helfritzsch H; Schubert J
    Oncol Rep; 2003; 10(4):1035-8. PubMed ID: 12792766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening of novel genes differentially expressed in human renal cell carcinoma by suppression subtractive hybridization].
    Ai JK; Huang X; Wang YJ; Bai Y; Lu YQ; Ye XJ; Xin DQ; Na YQ; Zhang ZW; Guo YL
    Ai Zheng; 2002 Oct; 21(10):1065-9. PubMed ID: 12508644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal assignment of human genomic NotI restriction fragments in a two-dimensional electrophoresis profile.
    Yoshikawa H; de la Monte S; Nagai H; Wands JR; Matsubara K; Fujiyama A
    Genomics; 1996 Jan; 31(1):28-35. PubMed ID: 8808276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of kidney tumors in trichloroethylene exposed workers by comparative genomic hybridization and DNA sequence analysis].
    Schraml P; Zhaou M; Richter J; Brüning T; Pommer M; Sauter G; Mihatsch MJ; Moch H
    Verh Dtsch Ges Pathol; 1999; 83():218-24. PubMed ID: 10714214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma.
    Strefford JC; Stasevich I; Lane TM; Lu YJ; Oliver T; Young BD
    Cancer Genet Cytogenet; 2005 May; 159(1):1-9. PubMed ID: 15860350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.